The largest database of trusted experimental protocols
> Procedures > Health Care Activity > Mental Health Services

Mental Health Services

Mental Health Services encompass the diagnosis, treatment, and prevention of mental, emotional, and behavioral disorders.
These services include psychiatric hospitals, mental health clinics, support groups, and counseling.
Effective mental health services can improve quality of life, enhance coping skills, and promote overall well-being.
Reserchers can leverage AI-powered insights to optimize mental health protocols, compare treatment options, and improve patient outcomes.
By identifing the most effective mental health services from literature, pre-prints, and patents, researchers can advance the field and enhance the lives of those in need.

Most cited protocols related to «Mental Health Services»

We conducted a literature review of mental health services research publications over a five-year period (Jan 2005–Dec 2009), using the PubMed Central database. Data were taken from the full text of the research article. Criteria for identification and selection of articles included reports of original research and one of the following: (1) studies that were specifically identified as using mixed methods, either through keywords or description in the title; (2) qualitative studies conducted as part of larger projects, including randomized controlled trials, which also included use of quantitative methods; or (3) studies that “quantitized” qualitative data (Miles and Huberman 1994 ) or “qualitized” quantitative data (Tashakkori and Teddlie 1998 ). Per criteria used by McKibbon and Gadd (2004 (link)), the analysis had to be fairly substantial—for example, a simple descriptive analysis of baseline demographics of the participants was not sufficient to be included as a mixed method article. Further, qualitative studies that were not clearly linked to quantitative studies or methods were excluded from our review.
We next assessed the use of mixed methods in each study to determine their structure, function, and process. A taxonomy of these elements of mixed method designs and definition of terms is provided in Table 1 below. Procedures for assessing the reliability of the classification procedures are described elsewhere (Palinkas et al. 2010 ). Assessment of the structure of the research design was based on Morse’s (1991 (link)) taxonomy that gives emphasis to timing (e.g., using methods in sequence [represented by a “→”symbol] versus using them simultaneous [represented by a “+” symbol]), and to weighting (e.g., primary method [represented by capital letters like “QUAN”] versus secondary [represented in small case letters like “qual”]). Assessment of the function of mixed methods was based on whether the two methods were being used to answer the same question or to answer related questions and whether the intention of using mixed methods corresponded to any of the five types of mixed methods designs described by Greene et al. (1989 ) (Triangulation or Convergence, Complementarity, Expansion, Development, and Initiation or Sampling). Finally, the process or strategies for combining qualitative and quantitative data was assessed using the typology proposed by Cresswell and Plano Clark (2007 ): merging or converging the two datasets by actually bringing them together, connecting the two datasets by having one build upon the other, or embedding one dataset within the other so that one type of data provides a supportive role for the other dataset.

Taxonomy of mixed method designs

ElementCategoryDefinition
StructureQUAL → quanSequential collection and analysis of quantitative and qualitative data, beginning with qualitative data, for primary purpose of exploration/hypothesis generation
qual → QUANSequential collection and analysis of quantitative and qualitative data, beginning with qualitative data, for primary purpose of confirmation/hypothesis testing
Quan → QUALSequential collection and analysis of quantitative and qualitative data, beginning with quantitative data, for primary purpose of exploration/hypothesis generation
QUAN → qualSequential collection and analysis of quantitative and qualitative data, beginning with quantitative data, for primary purpose of confirmation/hypothesis testing
Qual + QUANSimultaneous collection and analysis of quantitative and qualitative data for primary purpose of confirmation/hypothesis testing
QUAL + quanSimultaneous collection and analysis of quantitative and qualitative data for primary purpose of exploration/hypothesis generation
QUAN + QUALSimultaneous collection and analysis of quantitative and qualitative data, giving equal weight to both types of data
FunctionConvergenceUsing both types of methods to answer the same question, either through comparison of results to see if they reach the same conclusion (triangulation) or by converting a data set from one type into another (e.g. quantifying qualitative data or qualifying quantitative data)
ComplementarityUsing each set of methods to answer a related question or series of questions for purposes of evaluation (e.g., using quantitative data to evaluate outcomes and qualitative data to evaluate process) or elaboration (e.g., using qualitative data to provide depth of understanding and quantitative data to provide breadth of understanding)
ExpansionUsing one type of method to answer questions raised by the other type of method (e.g., using qualitative data set to explain results of analysis of quantitative data set)
DevelopmentUsing one type of method to answer questions that will enable use of the other method to answer other questions (e.g., develop data collection measures, conceptual models or interventions)
SamplingUsing one type of method to define or identify the participant sample for collection and analysis of data representing the other type of method (e.g., selecting interview informants based on responses to survey questionnaire)
ProcessMergeMerge or converge the two datasets by actually bringing them together (e.g., convergence—triangulation to validate one dataset using another type of dataset)
ConnectHave one dataset build upon another data set (e.g., complementarity—elaboration, transformation, expansion, initiation or sampling)
EmbedConduct one study within another so that one type of data provides a supportive role to the other dataset (e.g., complementarity—evaluation: a qualitative study of implementation process embedded within an RCT of implementation outcome)
Publication 2010
Complement System Proteins Mental Health Services Specimen Collection
Nine focus groups were held, three in England and six in Scotland. Participants were recruited through community groups, selected to cover a range of attributes (age, sex, socio-economic status) that are known to be associated with mental health [23 ]. In addition, one focus group was carried out with mental health service users. Focus groups were made up of a maximum of eight participants, and a total of 56 people took part. Participants were asked to complete the Affectometer 2, and to discuss their concept of positive mental health and its relationship with items in this scale. All focus groups were taped and transcribed. Content analysis was used to identify items which participants across the groups found consistently confusing or difficult to understand and concepts relating to mental well-being which participants thought should be included in the scale. Full details of focus groups are reported elsewhere [21 ]. Factor loadings and completion rates for individual items from a general population survey were examined for each of the Affectometer 2 items [22 (link)].
Full text: Click here
Publication 2007
ARID1A protein, human Mental Health Services
The present study focuses on the EBPAS, which consists of 15 items measured on a 5-point Likert scale ranging from 0 (Not at all) to 4 (To a very great extent) (Aarons, 2004 (link); Aarons, et al., 2007 (link)). The EBPAS is conceptualized as consisting of four lower-order factors/subscales and a higher-order factor/total scale (i.e., total scale score), the latter representing respondents’ global attitude toward adoption of EBPs. For the lower-order factors, Appeal assesses the extent to which the provider would adopt an EBP if it were intuitively appealing, could be used correctly, or was being used by colleagues who were happy with it. The Requirements factor assesses the extent to which the provider would adopt an EBP if it were required by an agency, supervisor, or state. The Openness factor assesses the extent to which the provider is generally open to trying new interventions and would be willing to try or use more structured or manualized interventions. The Divergence factor assesses the extent to which the provider perceives EBPs as not clinically useful and less important than clinical experience.
As described in Aarons (2004) (link), content validity of the EBPAS was based on initial development of a pool of items generated from literature review, consultation with mental health service providers, and consultation with mental health services researchers with experienced in evidence-based protocols. As additional evidence of content validity we also asked an expert panel of six mental health services researchers to rate each item of the EBPAS in terms of a) relevance in assessing attitudes toward evidence-based practice, b) importance in assessing attitudes toward evidence-based practice, and c) how representative the item is of the particular factor it is attempting to assess on a 5-point Likert scale (e.g., 1 = “not at all relevant”, 2 = “relevant to a slight extent”, 3 = “relevant to a moderate extent”, 4 = “relevant to a great extent”, 5 = “relevant to a very great extent”) . For individual items the mean rating across panel members ranged from 3.33 - 4.67 for relevance, 3.17- 4.67 for importance, and 3.17- 4.67 for representative. This result supports EBPAS content validity as every item was on average rated as at least “moderately” relevant, important, and representative of the factor it was purported to assess.
Previous studies suggest moderate to good internal consistency reliability in two samples for the total score (Cronbach’s α = .77, .79) and subscale scores excluding divergence (α range= .78-.93), with somewhat lower reliability estimates for divergence (α = .59, .66) (Aarons, 2004 (link); Aarons, et al., 2007 (link)). Construct validity in previous studies is supported by two previous scale development studies that have found acceptable model-data fit for previous confirmatory factor analysis models (Aarons, et al., 2007 (link)). In terms of construct and convergent validity, studies have found significant associations between EBPAS scores and mental health clinic structure and policies (Aarons, 2004 (link)), organizational culture and climate (Aarons & Sawitzky, 2006 (link)) and leadership (Aarons, 2006 (link)).
Publication 2010
Climate Mental Health Mental Health Services
The CRIS Oversight Committee (which evolved from the Stakeholder Committee, after CRIS received research ethics approval as a de-identified database) comprises the central governance entity overseeing security. Access to CRIS is application-based. Potential users submit an application to the CRIS Oversight Committee, in which they are asked to describe their project and the variables of interest. The committee, chaired by a mental health service user, also includes a child and adolescent mental health clinical representative, a representative of the Trust’s Caldicott Guardian, a Research Ethics representative, the CRIS academic project lead and the CRIS project manager. Potential applications looking to conduct audit of clinical services using CRIS need to gain approval from the relevant audit committee (within SLaM) before applying to use CRIS. Likewise, research project applicants need a senior university or NHS affiliated supervisor attached to and taking responsibility for the project and applicant before applying to use CRIS. Each applicant must have a formal affiliation in the form of an honorary or substantive contract with the hospital or the university before applying to access CRIS. These formally bind the applicant to the NHS duty of confidentiality when dealing with patient data (including de-identified patient data) [27 ].
Upon submission, the Oversight Committee determines whether a project is deemed suitable to access the CRIS database. “Suitability” is ascertained by verifying the need for the project, the scientific robustness of the application, and any patient confidentiality concerns to which the project may give rise. Any projects with the potential to identify patients, such as those investigating rare disorders or outcomes, are carefully discussed with the researcher and their supervisor and, where possible, alternatives provided (for example, the applicant is encouraged to obtain patient consent).
If researchers receive approval to use the CRIS system for the submitted project, they are permitted to access CRIS only within the SLaM security firewall and must follow a set of rules which facilitate responsible handling of data and uphold duties of confidentiality. All projects are audited weekly to ensure searches are being carried out within the remit of the submitted and approved project. Approval to use CRIS can be withdrawn in cases where inappropriate searches have been made in violation of the terms of the approved project. These procedures focus on close regulation of access to CRIS, as well as close monitoring of use of CRIS (Figure 3). The researcher must commit to ensuring that s/he will uphold the NHS duty of confidentiality when handling the data and adhere to the guidelines set out by CRIS (including not carrying data out of the Trust firewall for any purpose). In this way, the security model endeavours significantly to mould the researcher’s intentions – and hence behaviour – when encountering the data, so as to minimize any threats posed to patient anonymity identified above.
Full text: Click here
Publication 2013
Adolescent Child Clinical Audit Fungus, Filamentous Legal Guardians Mental Health Mental Health Services Patients Rare Diseases Secure resin cement
The study was conducted to present the evolution of relevant data from 2010 to 2014 based on a comparative analysis gathered from (1) a 2010 survey from Mental Health Department using the WHO-AIMS, a set of questionnaires developed by the WHO to assess mental health systems including policy and legislation, organization of mental health services, mental health in primary care, human resources, public education and link with other sectors, monitoring and research; and (2) Mental Health Department 2014 data reports regarding services evaluation and activities of the year 2014. The two data source covered information from all the health facilities with mental health services in the country, the province health directorates in all the ten provinces including the capital, and the Mental Health Department at Ministry of Health.
For the WHO-AIMS, the data collection instruments were translated, back-translated and then validated and adapted to Mozambican context. After back-translation a comparison between the original English version and the back-translated version was made to check if there were significant differences that could alter the response to the questionnaires. After being approved, the translated questionnaires were applied in two peripheral health units in the city and province of Maputo and in Mavalane Hospital which is located in an urban area in the city center.
A team of mental health professionals (psychologists, psychiatrists and psychiatric technicians) was trained to collect the data from health care facilities records, interviews and observational evaluation. There were two training sessions (total 8 h) to administer the questionnaires. Three psychologists gave training to the data collection team of the Department of Mental Health. This team was composed of psychologists and psychiatrists and led the research groups in each province. These researchers did a 2-h training session with local colleagues who have integrated teams in each province (usually two or three—psychologists, psychiatrists and psychiatric technicians) for data collection in the districts. Data collection took place from June to August 2010 in all the ten provinces of the country. A team from Mental Health Department conducted data collection in all health facilities with mental health services and at the administrative health directorates in each province. Data were filtered and summarized in Microsoft excel program and then introduced to the WHO-AIMS Excel Data Entry Program.
Mental health Department compiles annually data reports from information gathered from all the health facilities with mental health services that are compiled by the province coordinators. Data from the ten provinces are sent to Mental Health Department for the Mental Health Annual Report. Information regarding diagnostic, patients, human resources, services organization, psychotropic drugs availability, prevention and promotion activities were collected using a parallel information system that has been used since 2006 and has been improved as result of the WHO-AIMS report. For this study, data from 2014 compiled in January 2015 was the main source of information [26 ].
Full text: Click here
Publication 2016
Biological Evolution Diagnosis Manpower Mental Health Mental Health Services Patients Primary Health Care Psychiatrist Psychotropic Drugs Respiratory Diaphragm

Most recents protocols related to «Mental Health Services»

The ten-item depression and anxiety symptom checklist (SCL-10) [50 (link), 71 (link)], well-being measured by WHO-5 [50 (link), 72 (link)], and disability measured by a modified Sheehan Disability Scale (mSDS) are the established treatment effect parameters by the Mental Health Services of the Capital Region of Denmark.
Tertiary endpoints are three measurements of psychosocial remission defined as a WHO-5 score of > 49, an SCL-10 score of < 26 and an mSDS score of < 10. Additional tertiary clinical endpoints are changes in wellness (WHO-5), disability (mSDS), and symptomatology on the Brief Symptom Inventory 18 (BSI-18) and the SCL-10.
Two questionnaires assessing the negative effects of psychological and antidepressant treatment will be sent at the first follow-up, at the end of the treatment package. We use the Patient-Reported Inventory of Side-Effects (PRISE), originally developed and validated in Danish and also used in the STAR*D trial [71 (link), 73 (link)]. The questionnaire is omitted if the patient has not been or is not on antidepressant medication. We use the short 20-item form of the Negative Effects Questionnaire (NEQ) to assess adverse and unwanted events in psychological treatment, i.e., new symptoms, dependency, stigma, hopelessness, and the experienced quality of treatment [74 (link), 75 (link)]. Both baseline characteristics and treatment experiences, e.g., negative effects on the NEQ, will be used to investigate reasons for CBT and treatment package drop-out.
Full text: Click here
Publication 2023
Antidepressive Agents Anxiety Disabled Persons Mental Health Services Patients
The study was approved by the Medical Science Research Ethics Committee of the First Affiliated Hospital of China Medical University (approval reference number [2012]25–1). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants provided written informed consent by themselves or by their parents/guardians if they were under 18 years old after a complete description of the study. SZ and GHR participants were recruited from the inpatient and outpatient services at Shenyang Mental Health Center and the Department of Psychiatry at First Affiliated Hospital of China Medical University. Healthy controls (HC) participants were recruited from the local community by advertisement.
All components of the study were conducted at a single site and included both longitudinal and cross-sectional study cohorts, aged 13–45 years. All participants were evaluated by 2 trained psychiatrists to determine the presence or absence of Axis I psychiatric diagnoses using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV) Axis I Disorders (SCID) in those 18 years old and older and the Schedule for Affective Disorders and Schizophrenia for School-Age Children-present and Lifetime Version (K-SADS-PL) in those younger than 18 years. SZ participants met DSM-IV diagnostic criteria for SZ and not any other Axis I disorder. GHR participants were first-degree relatives of individuals with SZ and did not meet criteria for any DSM-IV Axis I disorder. HC participants did not have current or lifetime Axis I disorder or history of psychotic, mood, or other Axis I disorders in first-degree relatives as determined by detailed family history. Participants were excluded if any of the following were present: (1) the existence of substance/alcohol abuse or dependence or concomitant major medical disorder, (2) any magnetic resonance imaging (MRI) contraindications, and (3) history of head trauma with loss of consciousness for ≥ 5 min or any neurological disorder. Symptom severity was measured using the Brief Psychiatric Rating Scale (BPRS).
Full text: Click here
Publication 2023
Abuse, Alcohol Child concomitant disease Craniocerebral Trauma Diagnosis Diagnosis, Psychiatric Epistropheus Ethics Committees, Research Healthy Volunteers Homo sapiens Inpatient Legal Guardians Mental Disorders Mental Health Services Mood Mood Disorders Nervous System Disorder Outpatients Parent Psychiatrist Sadness Schizophrenia SCID Mice Youth
For recruitment, the study team compiled a list of mental and behavioral health facilities throughout Maryland via established service and provider networks and listings of mental health services on Maryland Department of Health websites. Recruitment materials were emailed to organizational directors, state regional mental and behavioral health authorities, and researcher personal network contacts in January 2021; contacts were asked to share the recruitment materials throughout their networks.
Interested organizations were instructed to have a CEO/Director, H.R. administrator, or clinical supervisor complete an eligibility survey, which collected information regarding the eligibility characteristics of the organization (e.g., size, services, location) and demographic information about their clientele (e.g., age, race, ethnicity, Medicaid recipients). The survey took an average of 41 min to complete. The research team staff reviewed these initial eligibility survey responses to compile a list of eligible organizations.
Publication 2023
Administrators Eligibility Determination Ethnicity Mental Health Services Respiratory Diaphragm
Key stakeholders were identified from and via an existing hoarding research group (https://www.northumbria.ac.uk/about-us/academic-departments/psychology/research/health-and-wellbeing/hoarding-research/), a multidisciplinary group (48 members) which brings together academics from English Universities, stakeholders from the Local Authorities, Housing Associations, Charities, Social Care Services, Mental Health Services, the NHS, and Emergency Services. Many of the key stakeholders were already members of this group, however members were also called upon to identify further key stakeholders (snowball sampling whereby participants suggest other individuals who could be invited to participate). Judgements about sample size, when to stop data collection and data saturation in thematic analysis are subjective, and therefore could not be determined (wholly) in advance of analysis [28 ] but based on previous work it was estimated that around two focus groups with 6–8 stakeholders each would provide sufficient data.
Full text: Click here
Publication 2023
Mental Health Services Service, Emergency Medical

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Age Groups Anxiety Diagnosis, Psychiatric Hypnotics Males Mental Health Services Mood Pandemics Patients Pharmaceutical Preparations Psychotropic Drugs Sleep

Top products related to «Mental Health Services»

Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Denmark, Austria, United Kingdom
Stata version 13 is a software package designed for data analysis, statistical modeling, and visualization. It provides a comprehensive set of tools for managing, analyzing, and presenting data. Stata 13 offers a wide range of statistical methods, including regression analysis, time-series analysis, and multilevel modeling, among others. The software is suitable for use in various fields, such as economics, social sciences, and medical research.
Sourced in United States, United Kingdom, Austria, Denmark
Stata 15 is a comprehensive, integrated statistical software package that provides a wide range of tools for data analysis, management, and visualization. It is designed to facilitate efficient and effective statistical analysis, catering to the needs of researchers, analysts, and professionals across various fields.
Sourced in United States, Japan, United Kingdom, Germany, Poland, Australia, Austria
SPSS Statistics version 25 is a software package used for interactive or batched statistical data analysis. It provides a comprehensive set of tools for data access, data management, and data analysis, as well as tools for model building and deployment.
Sourced in United States, United Kingdom, Japan, Thailand, China, Italy, Germany
SPSS version 18.0 is a statistical software package developed by IBM. It provides data management, analysis, and reporting capabilities. The core function of SPSS is to assist in the analysis of data and presentation of results.
Sourced in United States, United Kingdom, Denmark, Belgium, Spain, Canada, Austria
Stata 12.0 is a comprehensive statistical software package designed for data analysis, management, and visualization. It provides a wide range of statistical tools and techniques to assist researchers, analysts, and professionals in various fields. Stata 12.0 offers capabilities for tasks such as data manipulation, regression analysis, time-series analysis, and more. The software is available for multiple operating systems.
Sourced in United States, Denmark, United Kingdom, Canada, Austria
Stata 11 is a comprehensive statistical software package developed by StataCorp. It provides a wide range of data management, analysis, and visualization tools for researchers, students, and professionals across various fields. Stata 11 offers a flexible and user-friendly interface to handle complex data, perform advanced statistical analyses, and generate high-quality reports and graphics.
Sourced in United States, United Kingdom, Japan, China
SPSS software version 20.0 is a statistical analysis software package developed by IBM. It is designed to handle a wide range of data analysis tasks, including data management, statistical modeling, and reporting. The software provides a comprehensive set of tools for data manipulation, analysis, and visualization, making it a popular choice for researchers, analysts, and decision-makers across various industries.
Sourced in United States, Denmark, United Kingdom, Belgium, Japan, Austria, China
Stata 14 is a comprehensive statistical software package that provides a wide range of data analysis and management tools. It is designed to help users organize, analyze, and visualize data effectively. Stata 14 offers a user-friendly interface, advanced statistical methods, and powerful programming capabilities.
Sourced in United States, Denmark, United Kingdom, Austria, Sweden
Stata 13 is a comprehensive, integrated statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and graphical capabilities. Stata 13 is designed to handle complex data structures and offers a variety of statistical methods for researchers and analysts.

More about "Mental Health Services"

Mental health services encompass a wide range of interventions and support systems designed to address various mental, emotional, and behavioral disorders.
These services can include psychiatric hospitals, mental health clinics, support groups, counseling, and other specialized programs.
Leveraging insights from statistical software like SAS, Stata, and SPSS, researchers can optimize mental health protocols, compare treatment options, and improve patient outcomes.
The diagnosis, treatment, and prevention of mental health conditions are crucial for enhancing quality of life, developing effective coping strategies, and promoting overall well-being.
AI-powered analytics can help identify the most impactful mental health services from the vast body of research, pre-prints, and patents, enabling researchers to advance the field and better serve those in need.
Key aspects of mental health services include: - Psychiatric hospitalization for acute care and stabilization - Outpatient mental health clinics and community-based programs - Individual, group, and family counseling and psychotherapy - Medication management and pharmacological interventions - Peer support groups and recovery-oriented services - Preventive measures and mental health promotion initiatives By leveraging the capabilities of statistical software like SAS v9.4, Stata v13-v15, SPSS v18.0-v25, researchers can analyze large datasets, compare treatment outcomes, and develop optimal mental health protocols.
This data-driven approach can lead to more effective, personalized, and evidence-based mental health services, ultimately enhancing the lives of those living with mental, emotional, and behavioral challenges.
Ooher Terms: Mental Health, Psychiatric Services, Counseling, Behavioral Health, Emotional Well-being, SAS, Stata, SPSS